Claims
- 1. A composition comprising
- a) a non-woven material containing a mixture of polymeric biguanides subject to desorbtion when the non-woven material is wetted by urine; and
- b) an anionic polymer which is substantially insoluble in urine, said anionic polymer functioning to retain said biguanides on said material when contacted by urine.
- 2. A composition as claimed in claim 1 wherein the non-woven material is cellulose.
- 3. A composition as claimed in claim 2 wherein the cellulose is a chemical wood pulp.
- 4. A composition as claimed in claim 1 wherein the mixture of polymeric biguanides is a mixture of poly(hexamethylene biguanides) of formula (2) ##STR6## wherein n is from 2 to 40.
- 5. A composition as claimed in claim 1 wherein the anionic polymer is substantially insoluble in urine.
- 6. A composition as claimed in claim 1 wherein the anionic polymer contains carboxylic acid groups.
- 7. A composition as claimed in claim 1 where the anionic polymer is polyacrylic acid or a copolymer of acrylic acid with one or more non-ionic monomers.
- 8. A composition as claimed in claim 1 wherein at least some of the anionic groups of the anionic polymer are in free-acid form.
- 9. A composition as claimed in claim 1 wherein the anionic polymer is a super absorbent.
- 10. A process for forming an absorbent layer for use in a disposable article which comprises adding an anionic polymer to non-woven fibres containing a mixture of polymeric biguanides which are subject to desorbtion by urine, the anionic polymer being substantially insoluble in urine and functioning to retain the mixture of polymeric biguanides on said fibres.
- 11. A disposable article containing a composition as claimed in claim 1.
- 12. A composition according to claim 1 wherein the anionic polymer has a solubility in urine of not greater than 2% by weight.
- 13. A method of reducing the loss of antimicrobial biguanide bound to a non-woven material on exposure to urine which comprises adding to said non-woven material an anionic polymer which is substantially insoluble in urine.
Priority Claims (1)
Number |
Date |
Country |
Kind |
9515896 |
Aug 1995 |
GBX |
|
Parent Case Info
This application is the national phase of international application PCT/GB96/01562 filed Jun. 28, 1996 which designated the U.S.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/GB96/01562 |
6/28/1996 |
|
|
1/29/1998 |
1/29/1998 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO97/05910 |
2/20/1997 |
|
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
174 128 |
Mar 1986 |
EPX |